Back to Results
First PageMeta Content
HIV/AIDS / ViiV Healthcare / Fixed dose combination / GlaxoSmithKline / Pfizer / Zidovudine / Lamivudine / Intel Viiv / Abacavir/lamivudine / Medicine / Health / Pharmacology


PRESS RELEASE ANNOUNCEMENT
Add to Reading List

Document Date: 2012-05-01 15:28:24

Open Document

File Size: 38,74 KB

Share Result on Facebook

City

Triangle Park / London / /

Company

Pfizer / ViiV Healthcare / GlaxoSmithKline plc. / Public Private Partnership / /

Country

United States / /

Currency

GBP / /

Event

Funding / Business Partnership / Legal Issues / Company Expansion / /

Facility

US headquarters / /

IndustryTerm

HIV treatment / in-line products / pharmaceutical industry / treatment of HIV / prevention of HIV / sustained investment / HIV prevention / HIV care / healthcare / marketed products / /

MedicalCondition

HIV / chronic disease / HIV/AIDS / infection / illness / /

Organization

Children Fund / /

Person

Manuel Goncalves / Dominique Limet / Subesh Williams / John Pottage / /

/

Position

Chief Financial Officer / Chief Medical Officer / Chief Executive Officer / treatment and care CEO / Private / Head / /

Product

abacavir sulfate / lamivudine / Selzentry / Epzicom / /

ProvinceOrState

North Carolina / /

URL

www.viivhealthcare.com / /

SocialTag